Regine buys KEY 13.89: Oragenics Appoints Key Hires to Drive Lantibiotic Platform Growth and Expansion

Oragenics, Inc. (NYSE: OGEN), a leader in the development of novel, effective antibiotics and oral care probiotics, today announced two new appointments to the Product Development team. Joining the company are Guojun (Shawn) Nie Ph.D., as Director of ... ...

18 people liked this